SAN DIEGO, Oct. 10, 2014 (GLOBE NEWSWIRE) -- HempMeds™ – a Medical Marijuana, Inc. (OTC Pink:MJNA) portfolio company and the world's most trusted supplier of cannabidiol (CBD)-rich hemp oil products – is bringing CBD-rich hemp oil products to New York as a sponsor and exhibitor of the International Cannabis Association's East Coast Regulatory Summit and Educational Conference. The organization is hosting the region's first and largest one-stop conference Oct. 11-13 at the Marquis Marriott Hotel in Times Square. New York is the most recent state to pass medical marijuana laws.
"HempMeds™ is honored to sponsor and support the International Cannabis Association," states Andrew Hard, Director of Public Relations for HempMeds™. "We are showing attendees that cannabis is for people – and pets, too! Our participation shows just how far advances in CBD-rich hemp oil have come in one year and reinforces that these innovative products are available in all 50 states. From people of all ages – and now to their beloved pets – CBD-rich hemp oil is readily available to play a role in our daily lives."
Geared toward mentoring entrepreneurs interested in establishing businesses in the cannabis industry, the International Cannabis Association conference offers entrepreneurs a cannabis industry certification course, Regulatory Summit featuring New York Sen. Diane Savino and fundraiser for Sen. Savino, an evening networking reception hosted by HempMeds™, more than 40 presentations and an expo floor featuring cannabis-based businesses.
"We are honored to have HempMeds™ as the Industry Party Sponsor at the East Coast Regulatory Summit and Educational Conference," states Dan Humiston, co-Founder of the International Cannabis Association. "HempMeds™ gives entrepreneurs real-world examples of innovations in cannabis products that are available to consumers today. The Company's products are making headline news around the world and we are thrilled that HempMeds™ will showcase a wide range of CBD-rich hemp oil products for entrepreneurs to consider immediately including in their business models."
Hard concludes, "We are very encouraged by the recent passing of New York's medical marijuana laws giving 'whole plant' access to residents. Medical Marijuana, Inc. and their portfolio companies believe in access for all to the 'whole plant.' At this time, there are 34 of the 50 states with some form of medical cannabis law on the books. Regardless of whether it is a CBD-only state, medical marijuana state or a state with no cannabis laws, HempMeds™ is able to provide its CBD-rich hemp oil to the masses – today. It is an honor to support the International Cannabis Association and their efforts to increase cannabis education and foster entrepreneurship. We look forward to discussions about CBD-rich hemp oil products throughout the event at HempMeds'™ booth."
The International Cannabis Association's conference is October 11-13 at New York's Marquis Marriott Hotel located at 1535 Broadway, New York, NY 10036. For more information, visit: www.InternationalCannabisAssociation.com.
For more information on HempMeds and their CBD-rich hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation about CBD-rich hemp oil as it relates to HempMeds™ through the Company's social media websites on Facebook and Twitter.
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company's exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company's website at: www.MedicalMarijuanaInc.com
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
CONTACT: For further information, please contact: Investor Relations contact: Perry Coleman Medical Marijuana, Inc. P. 443-453-5088 firstname.lastname@example.org Public Relations contact: Andrew Hard Director of PR, HempMeds P. 858-380-5478 email@example.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc
Source:Medical Marijuana Inc